FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

41129511000001103: Mosunetuzumab (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 26-Oct 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2017881000001116 Mosunetuzumab en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2028131000001117 Mosunetuzumab (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mosunetuzumab Is a Antineoplastic agent true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Mosunetuzumab 1mg/1ml solution for infusion vials Has specific active ingredient True Mosunetuzumab Inferred relationship Existential restriction modifier
Mosunetuzumab 30mg/30ml solution for infusion vials Has specific active ingredient True Mosunetuzumab Inferred relationship Existential restriction modifier
Lunsumio 1mg/1ml concentrate for solution for infusion vials (Roche Products Ltd) Has specific active ingredient True Mosunetuzumab Inferred relationship Existential restriction modifier
Lunsumio 1mg/1ml concentrate for solution for infusion vials (Roche Products Ltd) 1 vial Has specific active ingredient True Mosunetuzumab Inferred relationship Existential restriction modifier
Lunsumio 30mg/30ml concentrate for solution for infusion vials (Roche Products Ltd) Has specific active ingredient True Mosunetuzumab Inferred relationship Existential restriction modifier
Mosunetuzumab 30mg/30ml solution for infusion vials 1 vial Has specific active ingredient True Mosunetuzumab Inferred relationship Existential restriction modifier
Lunsumio 30mg/30ml concentrate for solution for infusion vials (Roche Products Ltd) 1 vial Has specific active ingredient True Mosunetuzumab Inferred relationship Existential restriction modifier
Mosunetuzumab 1mg/1ml solution for infusion vials 1 vial Has specific active ingredient True Mosunetuzumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start